Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 1Neoplasm, Residual 1Hyperthermia 1Esophageal Squamous Cell Carcinoma 1

Interventions

Cyclophosphamide 22fludarabine phosphate 17Cyclosporine 15Peripheral Blood Stem Cell Transplantation 14Methotrexate 14Filgrastim 14Whole-Body Irradiation 11Mycophenolic Acid 11Busulfan 11Antilymphocyte Serum 11Radiotherapy 8Melphalan 8Exercise 8Dexamethasone 8Cytarabine 8Asparaginase 8venetoclax 7blinatumomab 7Vincristine 7Etoposide 7Daunorubicin 7fludarabine 6Methylprednisolone 6Mercaptopurine 6Granulocyte Colony-Stimulating Factor 6Therapeutics 5Psychiatric Rehabilitation 5Prednisone 4Immunotherapy, Adoptive 4Cord Blood Stem Cell Transplantation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Consolidation Chemotherapy × Clear all
NCT07003737 2025-06-04

Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation

First Affiliated Hospital of Zhejiang University

Phase NA Recruiting
114 enrolled
LymphoidOther hematologic neoplasm

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05026229 2021-10-01

A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Unknown
60 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡